TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NERV Stock 12 Month Forecast
Average Price Target
$4.50
▲(4.17% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Minerva Neurosciences in the last 3 months. The average price target is $4.50 with a high forecast of $5.00 and a low forecast of $4.00. The average price target represents a 4.17% change from the last price of $4.32.
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.
NERV Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
2
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
2
3
3
In the current month, NERV has received 0Buy Ratings, 3Hold Ratings, and 0Sell Ratings. NERV average Analyst price target in the past 3 months is 4.50.
Each month's total comprises the sum of three months' worth of ratings.
NERV Financial Forecast
NERV Earnings Forecast
Next quarter’s earnings estimate for NERV is -$0.30 with a range of -$0.49 to -$0.11. The previous quarter’s EPS was -$0.36. NERV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year NERV has Performed in-line its overall industry.
Next quarter’s earnings estimate for NERV is -$0.30 with a range of -$0.49 to -$0.11. The previous quarter’s EPS was -$0.36. NERV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year NERV has Performed in-line its overall industry.
NERV Sales Forecast
Next quarter’s sales forecast for NERV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NERV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year NERV has Performed in-line its overall industry.
Next quarter’s sales forecast for NERV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NERV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year NERV has Performed in-line its overall industry.
NERV Stock Forecast FAQ
What is NERV’s average 12-month price target, according to analysts?
Based on analyst ratings, Minerva Neurosciences’s 12-month average price target is 4.50.
What is NERV’s upside potential, based on the analysts’ average price target?
Minerva Neurosciences has 4.17% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NERV a Buy, Sell or Hold?
Minerva Neurosciences has a consensus rating of Hold which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
What is Minerva Neurosciences’s price target?
The average price target for Minerva Neurosciences is 4.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $5.00 ,the lowest forecast is $4.00. The average price target represents 4.17% Increase from the current price of $4.32.
What do analysts say about Minerva Neurosciences?
Minerva Neurosciences’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of NERV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.